Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycomics | 2 | 2021 | 118 | 0.860 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 138 | 0.710 |
Why?
|
| Polysaccharides | 1 | 2021 | 1020 | 0.470 |
Why?
|
| Prostatic Neoplasms | 6 | 2023 | 11094 | 0.330 |
Why?
|
| Glucuronosyltransferase | 1 | 2008 | 136 | 0.290 |
Why?
|
| Receptors, Androgen | 4 | 2008 | 1089 | 0.290 |
Why?
|
| Calcitriol | 2 | 2005 | 301 | 0.260 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2008 | 409 | 0.250 |
Why?
|
| Androgen Antagonists | 3 | 2023 | 1411 | 0.200 |
Why?
|
| Fucosyltransferases | 1 | 2021 | 118 | 0.180 |
Why?
|
| Gangliosides | 1 | 2021 | 132 | 0.180 |
Why?
|
| Androgens | 2 | 2008 | 1280 | 0.180 |
Why?
|
| Oligosaccharides | 1 | 2022 | 406 | 0.170 |
Why?
|
| Adenosine Triphosphatases | 1 | 2023 | 840 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 804 | 0.150 |
Why?
|
| Glycosylation | 1 | 2021 | 1099 | 0.150 |
Why?
|
| Mucins | 1 | 2021 | 569 | 0.150 |
Why?
|
| Milk, Human | 1 | 2022 | 490 | 0.140 |
Why?
|
| Erythropoietin | 1 | 2021 | 718 | 0.140 |
Why?
|
| Biological Transport | 1 | 2021 | 2083 | 0.140 |
Why?
|
| Immunity | 1 | 2022 | 1002 | 0.130 |
Why?
|
| Gene Expression | 3 | 2022 | 7585 | 0.120 |
Why?
|
| Prostate | 1 | 2023 | 1760 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2021 | 2721 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2353 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2882 | 0.110 |
Why?
|
| Autistic Disorder | 1 | 2022 | 1238 | 0.100 |
Why?
|
| Receptors, Calcitriol | 2 | 2005 | 361 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 2210 | 0.080 |
Why?
|
| RNA Interference | 3 | 2008 | 2829 | 0.080 |
Why?
|
| Dihydrotestosterone | 1 | 2008 | 194 | 0.070 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2008 | 123 | 0.070 |
Why?
|
| Receptors, Steroid | 1 | 2008 | 157 | 0.070 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2008 | 202 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2008 | 303 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 1168 | 0.070 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 319 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 597 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2021 | 4747 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2021 | 3789 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 741 | 0.060 |
Why?
|
| Tosyl Compounds | 1 | 2004 | 115 | 0.060 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2011 | 1536 | 0.050 |
Why?
|
| Infant | 2 | 2022 | 36459 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2008 | 17089 | 0.050 |
Why?
|
| Prognosis | 1 | 2023 | 29959 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2022 | 114 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2011 | 2463 | 0.050 |
Why?
|
| Anilides | 1 | 2004 | 413 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2008 | 2931 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2004 | 23618 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 1627 | 0.040 |
Why?
|
| Saccades | 1 | 2022 | 230 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 5795 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2022 | 42577 | 0.040 |
Why?
|
| Humans | 11 | 2023 | 766812 | 0.040 |
Why?
|
| Nitriles | 1 | 2004 | 981 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3139 | 0.030 |
Why?
|
| Disease Progression | 2 | 2011 | 13642 | 0.030 |
Why?
|
| Male | 7 | 2023 | 364154 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2008 | 5022 | 0.020 |
Why?
|
| Transfection | 2 | 2008 | 5755 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 2008 | 64 | 0.020 |
Why?
|
| Chromones | 1 | 2008 | 148 | 0.020 |
Why?
|
| Flutamide | 1 | 2008 | 95 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 294 | 0.020 |
Why?
|
| Oxidants | 1 | 2008 | 168 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11876 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 713 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2005 | 42 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 33 | 0.020 |
Why?
|
| Morpholines | 1 | 2008 | 584 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2005 | 109 | 0.010 |
Why?
|
| Testis | 1 | 2008 | 786 | 0.010 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2005 | 62 | 0.010 |
Why?
|
| Gelsolin | 1 | 2005 | 189 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 463 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2470 | 0.010 |
Why?
|
| COS Cells | 1 | 2005 | 1135 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2005 | 333 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 565 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 928 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4570 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2629 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 715 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 6105 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2008 | 2493 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 1130 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4143 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6066 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 1751 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 1982 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 5749 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 8310 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11218 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 9326 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2887 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 11062 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15564 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 2979 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 22248 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 14473 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10451 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 18986 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8623 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40149 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7869 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9613 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 59548 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12159 | 0.000 |
Why?
|
| Animals | 2 | 2008 | 168939 | 0.000 |
Why?
|
| Mice | 1 | 2008 | 81898 | 0.000 |
Why?
|
| Aged | 1 | 2011 | 171344 | 0.000 |
Why?
|
| Middle Aged | 1 | 2011 | 223267 | 0.000 |
Why?
|
Concepts
(114)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_